Schedule 13D ownership disclosure
Regulus Therapeutics Inc.
Security class unavailable · CUSIP: 75915K101
Event date: 2015-07-22
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.5700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-15-273154
- Form type
- SC 13D
- Filer
- IONIS PHARMACEUTICALS INC
- CIK
- CIK 874015
- Filed
- Jul 31, 2015
- Reporting period
- Jul 22, 2015
- Description
- Schedule 13D beneficial ownership